Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

Demand for weight loss and diabetes drugs has trounced supply for months, pushing Eli Lilly and rival Novo Nordisk to invest billions to ramp up manufacturing…

Demand for weight loss and diabetes drugs has trounced supply for months, pushing Eli Lilly and rival Novo Nordisk to invest billions to ramp up manufacturing…
Read More

About Author

Rubi Schildgen

See author's posts

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

About Author

Rubi Schildgen

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

No QoL Downside With Adding Nivo to Chemo in Urothelial Cancer

E-cigarette Use May Alter Healthy Nasal Mucosa

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

Budget FY25: Pharmaceuticals sector needs a major boost with increased focus on R&D and innovation

Dental veneers: Everything you need to know

Cheeky diet soft drink getting you through the work day? Here’s what that may mean for your health

UK teenagers get two-thirds of their calories from ultra-processed foods—new study

Some have called this area a birthing ‘desert.’ A nurse midwife is working to change that

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories